Delivery Order SPE2DB20D3103-SPE2DB25FP4N6

Award Date 7/10/25
Potential Completion Date 7/11/25
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE UD 100S, a pharmaceutical product, with a ceiling value of $13,155.36 and a performance period ending on July 11, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not set aside for any specific business type....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300 MG CAPSULE UD 100S. The contract has a firm fixed price, a ceiling value of $11,383.20, and an ultimate completion date of June 24, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania,...
This is a $23,700.95 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of RIFAMPIN 300 MG CAPSULE 60S, with an ultimate completion date of May 23, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. The company holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, with a ceiling value of $5,991.41 and a completion date of July 14, 2025. The contract is a firm-fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,187.50 firm-fixed-price contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medication. The order has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The company also holds a significant...
This is a $3,733.98 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is to provide RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is not set-aside and was awarded on June 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a type of antibiotic medication. The contract has a firm fixed price ceiling value of $4,152.73 and a period of performance through May 29, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300MG CAP 60S. The contract has a ceiling value of $7,350.32 and is a firm fixed-price delivery order, with an ultimate completion date of August 1, 2025. The contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medication, with a firm fixed price of $1,848.78 and a completion date of May 15, 2025. The contract is not set aside and was awarded on May 14, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,601.13 firm-fixed-price contract is for the delivery of RIFAMPIN 300 MG CAPSULE 30S, with a performance period extending through July 14, 2025. The award is not designated as a set-aside and represents an open competition. Amerisourcebergen Drug Corp is a significant supplier of pharmaceuticals and medical supplies to federal agencies, holding a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP4N6
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $4,432.36. The contract type is a Delivery Order, with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of July 11, 2025.

Amerisourcebergen Drug Corp is a large, for-profit corporate entity that serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is not set aside and is open to full and open competition.

Generated 10/12/25, 1:09 AM